Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
Baxter To Acquire Prism

April 18, 2011
Baxter International has entered into a definitive agreement to acquire Prism Pharmaceuticals.   Read More »
Financial Report: Amylin 1Q11

April 18, 2011
Byetta sales were $128.0 million (-15%).  Read More »
Pharmatek Gains DEA Approval

April 18, 2011
Pharmatek Laboratories has been approved by the U.S. Drug Enforcement Agency (DEA) for the analysis of Schedules I through V controlled substances.  Read More »
Sanofi-Aventis, Stanford in Research Pact

April 18, 2011
Sanofi-Aventis has entered a research collaboration through the Stanford University Bio-X program that supports, organizes and facilitates collaborative research projects in the early phases of development.   Read More »
GSK To Shed Non-core OTC Products

April 15, 2011
GSK plans to divest non-core OTC brands in an effort to focus on its Consumer Healthcare business around a portfolio of priority brands and emerging markets.   Read More »
Gerresheimer Manufactures Sanofi-Aventis Insulin Pen

April 15, 2011
Gerresheimer AG began commercial production of ClikSTAR insulin pens for Sanofi-Aventis.   Read More »
Pfizer’s Oral JAK Trial Meets RA Endpoint

April 15, 2011
Pfizer achieved positive results from the ORAL Scan Phase III study of tofacitinib, an investigational oral JAK inhibitor, in patients with moderate-to-severe active rheumatoid arthritis (RA) who had an inadequate response to methotrexate (MTX).  Read More »
Galapagos Stops Phase II RA Trial

April 15, 2011
Galapagos NV will discontinue its Phase II trial for GLPG0259 in rheumatoid arthritis (RA) following a planned interim analysis that did not support continuing development of the drug for RA.   Read More »
Merck, J&J Settle Rights Dispute

April 15, 2011
Remicade, Simponi rights in several regions go to J&J, along with cash and profit-split  Read More »
J&J Unit Recalls Topamax Lots Over Smell

April 14, 2011
The Ortho-McNeil Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. (itself a division of Johnson & Johnson) is voluntarily recalling two lots of Topamax (topiramate) 100mg Tablets, shipped between 10/19/2010 and 12/28/2010, and distribute  Read More »
Financial Report: Roche 1Q

April 14, 2011
Pharmaceuticals Division sales were down 2% in the quarter.   Read More »
Axcan Acquires Mpex Pharma

April 14, 2011
Axcan has entered into an agreement to acquire Mpex Pharmaceuticals, Inc. and its lead product candidate, Aeroquin, a new aerosol formulation of levofloxacin.   Read More »
Watson’s NJ Facility Named Corporate HQ

April 14, 2011
Watson Pharmaceuticals, Inc. has formally designated its Parsippany, NJ facility as its new corporate headquarters.   Read More »
West Adds Manufacturing Capacity

April 13, 2011
West Pharmaceutical Services, Inc. is adding manufacturing capacity for the Daikyo Crystal Zenith 1mL syringe system for biopharmaceutical drug packaging and delivery.  Read More »
Amunix, Biogen In Blood Factor Research Pact

April 13, 2011
Amunix, Inc. has entered into an exclusive worldwide research collaboration with Biogen Idec to research and develop novel, fully-recombinant blood factors (Factors IX, VIII and VIIa) with improved therapeutic properties.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: